. The cohesin complex promotes epidermal progenitor cell maintenance. Related to Figure 1 . (A) Epidermal progenitor cells were knocked down for control (CTL), SMC1A shRNAs (SMC1A-Bi), or SMC3 shRNAs (SMC3-Bi) through retroviral transduction. The SMC1A-B and SMC3-B shRNAs target a different region of SMC1A or SMC3 respectively using distinct sequences from the shRNAs shown in Figure 1 . RT-QPCR was used to determine the extent of SMC1A and SMC3 knockdown. QPCR results were normalized to GAPDH levels. Mean ± SEM, n=3. (B) RT-QPCR for differentiation gene expression in CTL, SMC1A-Bi, and SMC3-Bi cells. QPCR results were normalized to GAPDH levels. Mean ± SEM; n=3. (C) Control and knockdown cells were seeded at 100,000 cells and counted 7 days later. Cell number for each gene knockdown is represented as a percentage of control cell number. Mean ± SEM, n=3. (D) CTL and cohesin knockdown keratinocytes were seeded on devitalized dermis to regenerate human skin. Organotypic skin cultures were harvested 8 days after seeding the cells on dermis. Staining for differentiation protein (keratin 1) is shown in green. Hoechst staining in blue marks the nuclei. Brackets denote size of undifferentiated basal layer. Scale bar=40µm; n=3 regenerated human epidermis per group. (E) The thickness of the epidermis from the samples shown in (D) was measured from the bottom of the basal layer to the top of the epidermis. Mean ± SEM, n=3. (F) Human epidermal progenitor cell competition assay. GFP expressing control (CTL) keratinocytes were mixed at a 1:1 ratio with dsRed expressing SMC1Ai or SMC3i cells. The reverse experiment was also performed by taking dsRed-CTL cells and mixing at a 1:1 ratio with GFP expressing SMC1Ai or SMC3i cells. The mixed cells were used to regenerate human epidermis. GFP expressing cells are shown in green while dsRed cells are shown in red. Tissue was harvested at day 4 post-regeneration. Scale bar=20µm; n=3 for each of the 4 groups. The dashed white lines denote the basement membrane zone. (G) Quantitation of GFP and dsRED cells in the epidermis. 12 independent sections were quantitated using Image J per group to determine percent of GFP and dsRED contribution to the epidermis. *=p<0.05 (t-test) comparing CTL with SMC1Ai or SMC3i samples. RT-QPCR was used to determine the levels of GRHL3 mRNA upon SMC1A knockdown. Expression levels were normalized to GAPDH. Mean ± SEM, n=3. (E) Western blot on GRHL3 expression in CTL and SMC1A knockdown cells. Actin was used as a loading control. n=3. (F) Control or SMC1A knockdown cells were nucleofected with siRNAs to GRHL3 or control (scrambled siRNA sequence) in the following groups: 1) Control cells nucleofected with control siRNAs (CTL), 2) SMC1A knockdown cells nucleofected with control siRNAs (SMC1Ai+CTL), and 3) SMC1A knockdown cells nucleofected with GRHL3 siRNAs (SMC1Ai+GRHL3i). RT-QPCR was used to determine the levels of differentiation gene expression in the 3 groups. Expression levels were normalized to GAPDH. Mean ± SEM, n=3. *=p<0.05 (t-test) comparing CTL with SMC1Ai samples.
SUPPLEMENTAL MATERIALS AND METHODS

Retroviral transduction
The retroviral constructs (3ug) were transfected using Fugene 6 (Roche) into amphotropic phoenix cells to knockdown or overexpress genes. Viral supernatants were collected 48 hours post-transfection and used to infect primary human keratinocytes. Cells were incubated in the viral supernatants and centrifuged at 1000 rpm for 1 hour with hexadimethrine bromide (polybrene). Cells were transduced on two consecutive days with the shRNA retroviral constructs and once for the LZRS retroviral overexpression constructs.
Gene Knockdown and Overexpression
ShRNA retroviral constructs were generated by cloning oligos into the pSuper Retroviral vector (Mistry et al., 2012; Sen et al., 2004; Wang et al., 2015) . The oligo sequences targeting SMC1A and SMC3 are as follows: SMC1Ai: GGATGATATTAGTCAGGAA; SMC1A-Bi: GGAGATACAGTGGGTTCAT; SMC3i: GGACCAAGTAGAACAGGAA; SMC3-Bi: GGACTGTATTACTTTGGAA. The control shRNA construct was generated as previously described (Sen et al., 2010) . siRNAs used against GRHL3 were synthesized by Dharmacon against the following sequences: CATCAAGTCAGGCGAGTCA, CCACAGGAGTCGATGCTCT, CCAACAAAGTCAAGAGTGT, and TTGAGGAGGTGGCCTATAA as previously described (Mistry et al., 2012; Mistry et al., 2014) . The full-length open reading frame of SNAI2 was cloned into the LZRS retroviral vector using the restriction enzymes, ECORI and NOTI. The primers used to amplify SNAI2 were: SNAI2 for: ACGCAGAATTCGCCACCATGCCGCGCTCCTTCCTGGTCAAGAAGCA and SNAI2 rev: ACGCAGCGGCCGCTCAGTGTGCTACACAGCAGCCAGATTCCT as previously described (Mistry et al., 2014) .
Western blotting and immunofluorescence
40 ug of the cell lysates were used for immunoblotting and resolved on 10% SDS-PAGE and transferred to PVDF membranes. Primary antibodies used include B-actin (Abcam:ab8226) at 1:2000, GRHL3 (Novus Biologicals: NBP1-80356) at 1:500 and SNAI2 (Cell Signaling: 9585) at 1:300. Sheep anti rabbit HRP (Amersham Biosciences) secondary antibodies were used at 1:4000. For immunofluorescence experiments, cultured cells or tissue were fixed in 4% paraformaldehyde for 15 minutes followed by blocking in PBS with 2.5% normal goat serum, 0.3% triton X100, and 2% bovine serum albumin for 30 minutes. Cells were incubated in primary antibody (Transglutaminase I, Abcam: ab53995) at 1:300 for 1 hour. The secondary antibody used was Alexa 555 conjugated goat anti-mouse IgG (Molecular Probes: 1:1000). Tissue was incubated in primary antibody (Keratin 1, Biolegend: 905201) at 1:400 for 1 hour. The secondary antibody used was Alexa 488 conjugated goat anti-rabbit IgG (Molecular Probes: 1:1000). Nuclear dye, Hoechst 33342, was used at 1:1000 (Molecular Probes).
Quantitative reverse transcriptase-PCR analysis
Total RNA from cells was extracted using the GeneJET RNA purification kit (Thermo Scientific) and quantified by Nanodrop. One ug of total RNA was reverse transcribed using the Maxima cDNA synthesis kit from Fermentas. Quantitative PCR was performed using the Roche 480 Light Cycler. Samples were run in triplicate and normalized to GAPDH. Primer sequences for GAPDH, TGM1, GRHL3, IVL, LCE3D, UHRF1, and S100P were the same as previously published (Mistry et al., 2012; Sen et al., 2012; Sen et al., 2010; Sen et al., 2008) . Sequences for SNAI2, SCEL, SBSN, ACTL6A and FLG are as follows: SNAI2 for: CACCTCCTCCAAGGACCA, SNAI2 rev: GGCCAGCCCAGAAAAAGT; SCEL for: AAGCAGGCAGGACCACAG, SCEL rev: CCAAGGGTTTTCGGCAGT; SBSN for: CCGAGGGCTGAGCAATG, SBSN rev: TCTCATGGGCAACCTTGT; ACTL6A for: TCAGAGGCACCGTGGAAT; ACTL6A rev: AGCCATCGTGGACTGGAA; FLG for: GGCAAATCCTGAAGAATCCA; FLG rev: TGCTTTCTGTGCTTGTGTCC.
Apoptosis Assay
For apoptosis assays, cells were stained with Annexin V conjugated to Alexa Fluor 488 (A1320: Life Technologies) and analyzed using the Guava flow cytometer (Millipore) as previously described (Wang et al., 2015) .
Chromatin Immunoprecipitation Sequencing
Ten million cells were used for ChIP for each antibody used. Four micrograms of antibody was used for each pulldown experiment as previously described (Mistry et al., 2014) . QPCR results are represented as a percent of input DNA. ChIP was performed using the following antibodies: SNAI2 (Cell Signaling: 9585), SMC1A (Bethyl Laboratories: A300-055A), RNA Pol II (Covance: MMS-126R), H3K27ac (Active Motif: 39133) and Rabbit IgG (Abcam:37415). QPCR primers for the ACTL6A (promoter), UHRF1 (intron), SNAI2 sites A, B,C , GRHL3 TSS, ACTB TSS are as follows: ACTL6A for: GACAGGGCTGGTGAAGAAAG; ACTL6A rev: AGGTGCAACAATTGGCTTTG; UHRF1 for: CGGGCGTAGACTACTGGAAC; UHRF1 rev: TAGACACCAGATGGCAGCAG; SNAI2-A for: TTTACGAACTGAGCCCGTTT; SNAI2-A rev: GGGAGGAGCTGAAATCTGAA; SNAI2-B for: GCCAGCCTCTGGTGTTAATG; SNAI2-B rev: CTTCCCCCTTCCTTTTTCAA; SNAI2-C for: CCAGCACCATGTGGTAAAAA; SNAI2-C rev: GGCAGAAGGAAAGGAAACCT; GRHL3 for: GCGGGCTAAGAGTTAACAGC; GRHL3 rev: GACAGGTAGGTTCCCAGCAG; ACTB for: GCCATAAAAGGCAACTTTCG; ACTB rev: AGGGGAGAGGGGGTAAAAA. For ChIP-Seq, the ChIP DNA library was prepared using the TruSeq DNA sample prep (Illumina). Sequencing was done on a Hi-Seq System (Illumina) using single 1X100 reads at the Scripps Research Institute Next Generation Sequencing Core. Reads were mapped back to the human genome assembly (GRCh37/hg19). Peaks were called using the Partek Genomics Suite (Partek Incorporated) with p-value < 0.05 (Ji et al., 2008; Kharchenko et al., 2008) . The heat maps for the ChIP-Seq data was generated using seqMINER (Ye et al., 2011) .
Chromatin accessibility assay
Chromatin accessibility assays were performed on control and SMC1A knockdown cells using the Epiquik Chromatin Accessibility Assay Kit (P-1047-48) from Epigentek. This assay uses DNA nucleases to digest open chromatin whereas closed chromatin is protected from the nuclease. QPCR is then used to amplify the region of interest (DNA digested by the nuclease can't be amplified by the QPCR primers). The following primers were used for the SNAI2 genomic locus: SNAI2-A for: TTTACGAACTGAGCCCGTTT; SNAI2-A rev: GGGAGGAGCTGAAATCTGAA; SNAI2-B for: GCCAGCCTCTGGTGTTAATG; SNAI2-B rev: CTTCCCCCTTCCTTTTTCAA; SNAI2-C for: CCAGCACCATGTGGTAAAAA; SNAI2-C rev: GGCAGAAGGAAAGGAAACCT; ACTB for: GCCATAAAAGGCAACTTTCG; ACTB rev: AGGGGAGAGGGGGTAAAAA.
Gene expression profiling
Cells knocked down for SMC1A, SMC3, or control were harvested 10 days after the last infection. Microarray analysis was performed on duplicate samples. Labeling of cDNA and hybridization to Affymetrix HG-U133 2.0 plus arrays were performed at the UCSD Genechip Microarray Core Facility. For gene expression analysis, arrays were RMA normalized and differential expression was defined using the following filters: Significance Analysis of Microarrays 3.0 (Tusher et al., 2001 ) with a false discovery rate less than 5%, an average fold change ≥ 2, and an average raw expression intensity ≥ 100. Hierarchical clustering and heat map generation were performed as previously described (Mistry et al., 2012; Sen et al., 2010) . GO term enrichment was performed using DAVID analysis (Huang da et al., 2009 ) with the total set of genes on the appropriate microarray as the background. The epidermal differentiation gene signature (Sen et al., 2010) which was previously published by our group was used to compare to the SMC1A and SMC3 knockdown signatures.
Clonogenic assays
For clonogenic assays with primary human keratinocytes, 1,000 cells were plated onto mitomycin C treated (15ug/ml) 3T3 feeder cells in a 60 mm Petri dish. Colonies were fixed with cold methanol/acetone, stained using crystal violet (Fisher Scientific: S71262-1) and counted 4 weeks after plating. Assays were done as previously described (Mistry et al., 2012; Sen et al., 2010) .
Organotypic skin cultures
Regenerated human epidermis was generated by taking 1million keratinocytes and seeding it onto devitalized human dermis as previously described (Li and Sen, 2015; Sen et al., 2012) . Tissue was harvested 8 days after initial seeding.
In vivo epidermal progenitor cell competition assay Marked epidermal cells were generated by transducing the cells with a GFP or dsRed expressing retroviral construct. Cells were then transduced with retroviral constructs to knockdown SMC1A, SMC3, or control (CTL). GFP-CTL cells were mixed at a 1:1 ratio with either dsRed-SMC1Ai or dsRed-SMC3i cells. Experiments were also done with dsRed-CTL cells mixed at a 1:1 ratio with GFP-SMC1Ai or GFP-SMC3i cells. 500,000 GFP cells were mixed with 500,000 dsRed cells and then seeded on devitalized human dermis. The regenerated human skin was then grafted on immune compromised mice as previously described (Mistry et al., 2012; Wang et al., 2015) . 4 weeks post-grafting, the human skin grafts were harvested from the mice. The human skin grafts were fixed in 4% paraformaldehyde for 1 hour and sectioned. Imaging was performed to determine the contribution of GFP and dsRed expressing cells to the epidermis. ImageJ was used to quantitate the percentage of dsRed and GFP expressing cells in the epidermis. 12 independent sections were imaged per group.
